PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19223 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Zhixiang Wang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Burkitt Lymphoma, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education, National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
This PASS‐ALL study was designed to explore the effect of paediatric‐inspired versus adult chemotherapy regimens on survival of adolescents and young adults (AYA) with high‐risk Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia (HR PH‐ve B‐cell ALL) eligible for allogeneic haematopoietic stem cell transplantation (allo‐HSCT). The PASS‐ALL study is a multicentre, observational cohort study, and 143 patients with HR B‐cell PH‐ve ALL were enrolled from five centres—77 patients allocated in the paediatric‐inspired cohort and 66 in the adult cohort with comparable baseline characteristics. Of the 143 patients, 128 cases underwent allo‐HSCT. Three‐year leukaemia‐free survival (LFS) in the paediatric‐inspired cohort was 72.2% (95% CI 60.8%–83.6%) compared with 44.6% (95% CI 31.9%–57.3%; p = 0.001). Furthermore, time‐to‐positive minimal residual disease (TTP‐MRD) post‐HSCT was marked different, 3‐year cumulative incidence of relapse was 25.9% (95% CI 15.8%–37.2%) in paediatric cohort and 45.4% (95% CI 40.0%–57.9%) in adult cohort ( p = 0.026). Finally, the 3‐year OS rate was 75.3% (95% CI 64.9%–85.7%) for the paediatric‐inspired cohort and 64.1% (95% CI 51.8%–76.4%) for the adult cohort ( p = 0.074). On a multivariate analysis, paediatric‐inspired regimen is a predictive factor for LFS (HR = 2.540, 95% CI 1.327–4.862, p = 0.005). Collectively, our data suggest that paediatric‐inspired chemotherapy pre‐HSCT results in deeper and durable MRD response reduces relapse post‐HSCT and improves survival in HR B‐cell PH‐ve ALL patients with allo‐HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Clinical Medical Research, Center of Hematology Diseases of Guangdong Province, Guangzhou, China.
- Department of Hematology, People's Hospital of Ganzhou, Jiangxi, China.
- Department of Hematology, Wuzhou Gongren Hospital, Wuzhou, Guangxi, China.
- Department of Hematology, The 3rd Xiangya Hospital of Central South University, Changsha, China.
- Department of Hematology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
ORCID-Profile: Zhixiang Wang, Li Xuan, Qifa Liu, Hongsheng Zhou
Förderung
- Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Wang, Z., Fan, Z., Wu, Z., Xuan, L., Li, X., Tang, B., Liu, Y., He, J., Huang, K., Zhou, X., Gao, Y., Wang, Q., Li, X., Lin, R., Xu, N., Huang, F., Wang, S., Liang, X., Zhang, J., …, & Zhou, H. (2024). PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. https://doi.org/10.1111/bjh.19223
Vancouver
Wang Z, Fan Z, Wu Z, Xuan L, Li X, Tang B, et al. PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 2024. doi:10.1111/bjh.19223
BibTeX
@article{Wang2024,
author = {Wang, Zhixiang and Fan, Zhiping and Wu, Zhengwei and Xuan, Li and Li, Xin and Tang, Bingqing and Liu, Yiqian and He, Jiabao and Huang, Kangyu and Zhou, Xuan and Gao, Ya and Wang, Qiang and Li, Xiaofang and Lin, Ren and Xu, Na and Huang, Feng and Wang, Shunqing and Liang, Xingquan and Zhang, Jingdong and Liu, Xiaoli and Sun, Jing and Liu, Qifa and Zhou, Hongsheng},
title = {PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19223}
}
EUVIMED